The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation
Open accessPreprint — published as 10.1016/j.cell.2021.04.025 · Paper page
Abstract
We identified a novel SARS-CoV-2 variant by viral whole-genome sequencing of 2,172 nasal/nasopharyngeal swab samples from 44 counties in California. Named B.1.427/B.1.429 to denote its 2 lineages, the variant emerged around May 2020 and increased from 0% to >50% of sequenced cases from September 1, 2020 to January 29, 2021, exhibiting an 18.6-24% increase in transmissibility relative to wild-type circulating strains. The variant carries 3 mutations in the spike protein, including an L452R substitution. Our analyses revealed 2-fold increased B.1.427/B.1.429 viral shedding in vivo and increased L452R pseudovirus infection of cell cultures and lung organoids, albeit decreased relative to pseudoviruses carrying the N501Y mutation found in the B.1.1.7, B.1.351, and P.1 variants. Antibody neutralization assays showed 4.0 to 6.7-fold and 2.0-fold decreases in neutralizing titers from convalescent patients and vaccine recipients, respectively. The increased prevalence of a more transmissible variant in California associated with decreased antibody neutralization warrants further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“This variant showed reduced resistance to neutralization by convalescent (4–6.7-fold) and post-vaccination sera (2–2.9-fold) against this variant [38, 39].”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [38]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Kearse, M., Moir, R., Wilson, A., Stones-Havas, S., Cheung, M., Sturrock, S., Buxton, S., Cooper, A., Markowitz, S., Duran, C., et al. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts199 · Cited by 20,027
Posterior summarization in Bayesian phylogenetics using tracer 1.7
Rambaut, A., Drummond, A. J., Xie, D., Baele, G., & Suchard, M. A. (2018) · Systematic Biology · doi:10.1093/sysbio/syy032 · Cited by 11,159
Bayesian Phylogenetics with BEAUti and the BEAST 1.7
Drummond, A. J., Suchard, M. A., Xie, D., & Rambaut, A. (2012) · Molecular Biology and Evolution · doi:10.1093/molbev/mss075 · Cited by 10,063 · cited 3×
“The resulting maximum clade credibility (MCC) tree was generated using 530 TreeAnnotator v.2.6.3 (Drummond et al., 2012) and visualized using FigTree v.1.4.4 531 (Rambaut, 2021).”
MethodInfluentialStructure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
GISAID: Global initiative on sharing all influenza data – from vision to reality
Shu, Y., & McCauley, J. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.13.30494 · Cited by 3,039 · cited 7×
“508 Multiple sequence alignment of 6 B.1.427/B.1.429 genomes and the Wuhan Hu-1 509 prototypical genome (GISAID ID: EPI_ISL_402125, GenBank accession number 510 MN908947) was performed using the MAFFT aligner v7.”
MethodInfluentialA dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Rambaut, A., Holmes, E. C., O’Toole, Á., Hill, V., McCrone, J. T., Ruis, C., du Plessis, L., & Pybus, O. G. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0770-5 · Cited by 2,543
Research works printed but not linked: 2
- Chand, M. , Hopkins, S. , Dabreara, G. , Allen, H. , Lamagni, T. , Edeghere, O. , Achison, C. , Myers, R. , Barclay, W. , Ferguson, N. , et al. (2020). Investigation of SARS-CoV-2 variants of concern in England, P.H. England, ed. (Crown), pp. 11.
- Davies, N.G. , Jarvis, C.I. , Edmunds, W.J. , Jewell, N.P. , Diaz-Ordaz, K. , and Keogh, R.H. (2021). Increased hazard of death in community-tested cases of SARS-CoV-2 Variant of Concern 202012/01. medRxiv.
Cited by
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Ferreira, I. A. T. M., Datir, R., Collier, D. A., Albecka, A., Singh, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03944-y · Cited by 1,337
Fiolet, T., Kherabi, Y., MacDonald, C.-J., Ghosn, J., & Peiffer-Smadja, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.005 · Cited by 911
Tarke, A., Sidney, J., Methot, N., Yu, E. D., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., Wang, E., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100355 · Cited by 706
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Motozono, C., Toyoda, M., Zahradnik, J., Saito, A., Nasser, H., Tan, T. S., Ngare, I., Kimura, I., Uriu, K., Kosugi, Y., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.006 · Cited by 586
“429 lineage, which forms a single clade (Deng et al., 2021) (Figure 3A; Table S4).”
InfluentialOmicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance
Chen, J., Wang, R., Gilby, N. B., & Wei, G.-W. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c01451 · Cited by 653
Metadata
- Authors
- Deng, X., Garcia-Knight, M. A., Khalid, M. M., Servellita, V., Wang, C., Morris, M. K., Sotomayor-González, A., Glasner, D. R., Reyes, K. R., Gliwa, A. S., Reddy, N. P., Sanchez San Martin, C., Federman, S., Cheng, J., Balcerek, J., Taylor, J., Streithorst, J. A., Miller, S., Kumar, G. R., Sreekumar, B., Chen, P.-Y., Schulze-Gahmen, U., Taha, T. Y., Hayashi, J., Simoneau, C. R., McMahon, S., Lidsky, P. V., Xiao, Y., Hemarajata, P., Green, N. M., Espinosa, A., Kath, C., Haw, M., Bell, J., Hacker, J. K., Hanson, C., Wadford, D. A., Anaya, C., Ferguson, D., Lareau, L. F., Frankino, P. A., Shivram, H., Wyman, S. K., Ott, M., Andino, R., & Chiu, C. Y.
- Affiliations
- University of California, San Francisco (US)
- Gladstone Institutes (US)
- California Department of Public Health (US)
- Los Angeles County Department of Public Health (US)
- Monterey County Health Department (US)
- Innovative Genomics Institute (US)
- Corresponding author
- Andino, Raul
- Chiu, Charles Y.
- ORCID
- Deng, Xianding
- Garcia-Knight, Miguel A
- Khalid, Mir M.
- Servellita, Venice
- Wang, Candace
- Morris, Mary Kate
- Sotomayor-González, Alicia
- Glasner, Dustin R
- Reyes, Kevin R
- Federman, Scot
- Cheng, Jing
- Balcerek, Joanna
- Taylor, Jordan
- Miller, Steve
- Kumar, G. Renuka
- Sreekumar, Bharath
- Taha, Taha Y.
- Hayashi, Jennifer
- Simoneau, Camille R.
- McMahon, Sarah
- Lidsky, Peter V.
- Xiao, Yinghong
- Hemarajata, Peera
- Green, Nicole M.
- Bell, John
- Hacker, Jill K.
- Hanson, Carl
- Wadford, Debra A.
- Lareau, Liana F.
- Frankino, Phillip A.
- Shivram, Haridha
- Wyman, Stacia K.
- Andino, Raul
- Chiu, Charles Y.
- Venue
- Cell
- Publisher
- openRxiv
- Published
- 2021-03-09
- Volume
- 184
- Issue
- 13
- Pages
- 3426-3437.e8
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC7987058
- OpenAlex
- W3155554970
- Cited by
- 651
- References
- 55
- Citations by year
- 2026: 10 · 2025: 26 · 2024: 59 · 2023: 64 · 2022: 234 · 2021: 257
- FWCI
- 48.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- Funders
- California Department of Public Health (NU50CK000539)
- Roddenberry Foundation
- Innovative Genomics Institute
- National Institutes of Health (4r33ai120977-03)
- Centers for Disease Control and Prevention (U50CI000498, NU50CK000539, 6NU50CK000539, U01CK000539, NU50CK000498, 6 NU50CK000498)
- University of California, San Francisco
- Canadian Institutes of Health Research
- National Heart, Lung, and Blood Institute (R01HL105704)
- National Institute on Drug Abuse (DP1DA038043)
- National Institute of Allergy and Infectious Diseases (R33-AI120977, R21AI129455)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Keywords
- SARS-CoV-2, L452R mutation, spike protein mutations, viral transmissibility, viral shedding, antibody neutralization, N501Y mutation, convalescent sera, COVID-19 vaccines, lung organoids, California
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation. https://app.cochat.ai/papers/10.1101/2021.03.07.21252647
- The paper
- Deng, X., Garcia-Knight, M. A., Khalid, M. M., Servellita, V., Wang, C., Morris, M. K., Sotomayor-González, A., Glasner, D. R., Reyes, K. R., Gliwa, A. S., Reddy, N. P., Sanchez San Martin, C., Federman, S., Cheng, J., Balcerek, J., Taylor, J., Streithorst, J. A., Miller, S., Kumar, G. R., . . . Chiu, C. Y. (2021). Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation. Cell. https://doi.org/10.1101/2021.03.07.21252647
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.